Myozyme and erythema 
Myozyme and erythema Patient Reports February 12, 2012
Myozyme Side Effects Report #5237944-7
Myozyme side effect was reported by a Physician from NETHERLANDS on Jan 29, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, bronchospasm, cardiac arrest
, erythema, gastroenteritis , infusion related reaction, oedema peripheral, rash , vasoconstriction. Myozyme dosage: 40 MG/KG QWK IV. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5255123-4
Myozyme side effect was reported by a Physician from NETHERLANDS on Feb 14, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, autonomic nervous system imbalance, blood immunoglobulin e increased, bradycardia, bronchospasm, cardiac arrest
, eosinophilia, erythema, gastroenteritis . Myozyme dosage: 40 MG/KG QWK IV. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5325824-8
Myozyme side effect was reported by a Physician from GERMANY on Apr 26, 2007. Female patient, 58 years of age, weighting 159.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, erythema, oxygen saturation decreased, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5216727-8
Myozyme side effect was reported by a Consumer or non-health professional from FRANCE on Jan 04, 2007. Female patient, 45 years of age, weighting 123.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, back pain
, blood pressure decreased, chest discomfort, chest pain , erythema, flushing, infusion related reaction, nausea . Myozyme dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, POLARAMINE, TELFAST. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5154555-2
Myozyme side effect was reported by a Consumer or non-health professional from FRANCE on Oct 31, 2006. Female patient, 44 years of age, weighting 123.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: back pain
, blood pressure decreased, chest pain , erythema, face oedema, flushing, hypotension. Myozyme dosage: unknown. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5332845-8
Myozyme side effect was reported by a Physician from GREECE on May 11, 2007. Female patient, 40 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, flushing, infusion related reaction, lower respiratory tract infection, no therapeutic response, oedema peripheral, pharyngitis, pseudomonas infection, sputum culture positive. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5713823-3
Myozyme side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: ear infection
, erythema, infusion related reaction, lung disorder, oxygen saturation decreased, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5725882-2
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: ear infection
, erythema, glycogen storage disease type ii, infusion related reaction, lung disorder, oxygen saturation decreased, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5748505-5
Myozyme side effect was reported by a Physician from UNITED STATES on May 05, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chronic respiratory disease, ear infection
, erythema, infusion related reaction, pneumonia aspiration, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5829501-6
Myozyme side effect was reported by a Physician from UNITED STATES on July 17, 2008. Male patient, child 12 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abasia, anxiety
, arthralgia, asthenia, asthma , chest pain , dehydration, erythema, eye rolling. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5533877-7
Myozyme side effect was reported by a Physician from ITALY on Nov 14, 2007. Male patient, child 10 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dysphagia, erythema, infusion related reaction, throat tightness. Myozyme dosage: unknown. Patient recovered.
Myozyme Side Effects Report #5302484-3
Myozyme side effect was reported by a Physician from GERMANY on Mar 29, 2007. Female patient, weighting 159.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, erythema, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5106859-7
Myozyme side effect was reported by a Physician from BRAZIL on Aug 31, 2006. Male patient, weighting 19.82 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, complement factor increased, cyanosis, erythema, infusion related reaction, lethargy, oxygen saturation decreased, pallor, rash
. Myozyme dosage: 20 MG/KG IV. During the same period patient was treated with PROPRANOLOL, CAPTOPRIL, LASIX. Patient recovered.Myozyme Side Effects Report #5160220-8
Myozyme side effect was reported by a Physician from UNITED STATES on Nov 06, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: condition aggravated, conjunctival hyperaemia, disease progression, erythema, flushing, hypertrophic cardiomyopathy, infusion related reaction, muscular weakness, nausea
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5635628-4
Myozyme side effect was reported by a Physician from FRANCE on Feb 05, 2008. Female patient, weighting 13.67 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, crying, cyanosis, dyspnoea, erythema, infusion related reaction, moaning, nervousness, pyrexia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5678162-8
Myozyme side effect was reported by a Physician from FRANCE on Mar 05, 2008. Female patient, weighting 13.67 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, cyanosis, dyspnoea, erythema, hyperthermia, infusion related reaction, lacrimation increased, moaning, nervousness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LASIX, LEVOCARNIL, DEXTRIN. Patient recovered.
Myozyme Side Effects Report #5724268-4
Myozyme side effect was reported by a Physician from FRANCE on Apr 21, 2008. Female patient, weighting 13.67 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, crying, cyanosis, dyspnoea, erythema, hyperthermia, moaning, nervousness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LASIX, LEVOCARNIL, DEXTRIN. Patient recovered.
Myozyme Side Effects Report #5796377-5
Myozyme side effect was reported by a Physician from UNITED STATES on June 18, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac murmur, congestive cardiomyopathy, conjunctivitis, erythema, fatigue, heart rate increased, hypercapnia, hypotonia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LASIX, OXYGEN, ACETAMINOPHEN, MOTRIN. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5827019-8
Myozyme side effect was reported by a Physician from JAPAN on July 09, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSULPHATE. Patient recovered.Myozyme Side Effects Report #5828424-6
Myozyme side effect was reported by a Physician from JAPAN on July 23, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, inguinal hernia repair, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSULPHATE. Patient recovered.Myozyme Side Effects Report #5842948-7
Myozyme side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSTULFATE. Patient recovered.Myozyme Side Effects Report #5875740-8
Myozyme side effect was reported by a Health Professional from UNITED STATES on Aug 26, 2008. Male patient, weighting 20.06 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, bronchiolitis, choking
, conjunctivitis, erythema, influenza, infusion related reaction, pneumonia aspiration, respiratory arrest. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5887199-5
Myozyme side effect was reported by a Physician from JAPAN on Sept 02, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, erythema, infusion related reaction, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSULPHATE. Patient recovered.Myozyme Side Effects Report #6067772-4
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 27, 2009. Male patient, weighting 22.05 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, apnoea, bronchiolitis, cardio-respiratory arrest, chest x-ray abnormal, conjunctivitis, erythema, influenza, infusion related reaction. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 01/05/2009.
Myozyme Side Effects Report #6106803-X
Myozyme side effect was reported by a Physician from UNITED ARAB EMIRATES on Feb 22, 2009. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: diarrhoea, erythema, lung infection, rash erythematous, wheezing. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with STEROIDS, PARACETAMOL, PREDNISOLONE, METHYLPREDNISOLONE, ANTIHISTAMINES, HYDROCORTISONE, ACETAMINOPHEN, ZANTAC. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #6111297-4
Myozyme side effect was reported by a Physician from GREECE on Feb 27, 2009. Male patient, weighting 17.64 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cyanosis, erythema, hypersensitivity, hypotension, infusion related reaction, pruritus, rash
. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #6131096-7
Myozyme side effect was reported by a Physician from UNITED ARAB EMIRATES on Mar 10, 2009. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, blood immunoglobulin g increased, diarrhoea, dysphagia, erythema, hypotonia, infusion related reaction, lung infection. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with STEROIDS, ACETAMINOPHEN, PREDNISOLONE, METHYLPREDNISOLONE, ANTIHISTAMINES, HYDROCORTISONE, ZANTAC. Patient was hospitalized. Patient recovered.